95 related articles for article (PubMed ID: 28434299)
1. First report of MYD88
Chakraborty R; Novak AJ; Ansell SM; Muchtar E; Kapoor P; Hayman SR; Dispenzieri A; Buadi FK; Lacy MQ; King RL; Gertz MA
Amyloid; 2017 Mar; 24(sup1):42-43. PubMed ID: 28434299
[No Abstract] [Full Text] [Related]
2. First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.
Chakraborty R; Novak AJ; Ansell SM; Muchtar E; Kapoor P; Hayman SR; Dispenzieri A; Buadi FK; Lacy MQ; King RL; Gertz MA
Blood; 2016 Jun; 127(23):2936-8. PubMed ID: 27034430
[No Abstract] [Full Text] [Related]
3. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
4. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P.
Zagaria A; Coccaro N; Tota G; Anelli L; Minervini A; Casieri P; Cellamare A; Minervini CF; Brunetti C; Ricco A; Orsini P; Cumbo C; Specchia G; Albano F
Blood Cells Mol Dis; 2015 Jan; 54(1):51-2. PubMed ID: 25159121
[TBL] [Abstract][Full Text] [Related]
6. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
Jiménez C; Sebastián E; Chillón MC; Giraldo P; Mariano Hernández J; Escalante F; González-López TJ; Aguilera C; de Coca AG; Murillo I; Alcoceba M; Balanzategui A; Sarasquete ME; Corral R; Marín LA; Paiva B; Ocio EM; Gutiérrez NC; González M; San Miguel JF; García-Sanz R
Leukemia; 2013 Aug; 27(8):1722-8. PubMed ID: 23446312
[TBL] [Abstract][Full Text] [Related]
7. IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features.
Sidana S; Larson DP; Greipp PT; He R; McPhail ED; Dispenzieri A; Murray DL; Dasari S; Ansell SM; Muchtar E; Gonsalves WI; Kourelis TV; Ramirez-Alvarado M; Kapoor P; Rajkumar SV; Lacy MQ; Buadi FK; Leung N; Kyle RA; Kumar SK; King RL; Gertz MA
Leukemia; 2020 May; 34(5):1373-1382. PubMed ID: 31780812
[TBL] [Abstract][Full Text] [Related]
8. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
9. Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?
Kidoguchi K; Kojima K; Seki R; Nagafuji K; Ohshima K; Kimura S
Int J Hematol; 2019 Mar; 109(3):247-248. PubMed ID: 30604315
[No Abstract] [Full Text] [Related]
10. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
Willenbacher W; Willenbacher E; Brunner A; Manzl C
Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
[No Abstract] [Full Text] [Related]
11. Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κ.
Narita K; Kobayashi H; Suzuki T; Ichikawa D; Yamazaki K; Terawaki H; Suehara Y; Miura D; Takeuchi M; Matsue K
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e805-e808. PubMed ID: 32660905
[No Abstract] [Full Text] [Related]
12. Synergistic cooperation and crosstalk between
Wang JQ; Jeelall YS; Humburg P; Batchelor EL; Kaya SM; Yoo HM; Goodnow CC; Horikawa K
J Exp Med; 2017 Sep; 214(9):2759-2776. PubMed ID: 28701369
[No Abstract] [Full Text] [Related]
13. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
14. MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Poulain S; Boyle EM; Roumier C; Demarquette H; Wemeau M; Geffroy S; Herbaux C; Bertrand E; Hivert B; Terriou L; Verrier A; Pollet JP; Maurage CA; Onraed B; Morschhauser F; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Br J Haematol; 2014 Nov; 167(4):506-13. PubMed ID: 25160558
[TBL] [Abstract][Full Text] [Related]
15. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.
Jiménez C; Chillón Mdel C; Balanzategui A; Puig N; Sebastián E; Alcoceba M; Sarasquete ME; Conde IP; Corral R; Marín LA; Paiva B; Ruano M; Antón A; Maldonado R; San Miguel JF; González M; García-Sanz R
Appl Immunohistochem Mol Morphol; 2014; 22(10):768-73. PubMed ID: 24992174
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples.
Staiger AM; Ott MM; Parmentier S; Rosenwald A; Ott G; Horn H; Griese EU
Br J Haematol; 2015 Oct; 171(1):145-8. PubMed ID: 25816840
[No Abstract] [Full Text] [Related]
17. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
18. IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Minervini CF; Brunetti C; Impera L; Ricco A; Cellamare A; Specchia G; Albano F
Ann Hematol; 2014 Sep; 93(9):1605-7. PubMed ID: 24408161
[No Abstract] [Full Text] [Related]
19. Origin of Waldenstrom's macroglobulinaemia.
García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
[TBL] [Abstract][Full Text] [Related]
20. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
